Printer Friendly

TARGETED GENETICS ELECTS O'NEILL DIRECTOR

 TARGETED GENETICS ELECTS O'NEILL DIRECTOR
 SEATTLE, Nov. 5 /PRNewswire/ -- Targeted Genetics Corp. (TGC)


announced today the election of Donald E. O'Neill as director, increasing board membership to three.
 O'Neill was executive vice president and chairman of International Operations at Warner-Lambert Co. for over 20 years and is a past chairman of Warner's Pharmaceutical Review Board. He retired in 1990.
 "Don O'Neill brings over 40 years of experience in the pharmaceutical industry to TGC, and as director will help guide the company during one of the most productive periods in its development," said H. Stewart Parker, TGC president and chief executive officer.
 O'Neill is a board member of Scios Nova Inc., Alliance Pharmaceutical Corp. and ImmunoGen Inc.
 Targeted Genetics Corp. is a leader in the development of gene therapy treatments for acquired and inherited diseases. The company has begin its first human clinical trial, a gene therapy-based treatment for HIV infection.
 -0- 11/5/92
 /CONTACT: H. Stewart Parker of Targeted Genetics, 206-623-7612/ CO: Targeted Genetics Corp. ST: Washington IN: MTC SU: PER


SW-JH -- SE002 -- 2896 11/05/92 09:15 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Nov 5, 1992
Words:181
Previous Article:NEW YORK STATE ELECTRIC & GAS CORPORATION FILES PETITION FOR CURTAILING POWER PURCHASES
Next Article:VIKING OFFICE PRODUCTS INC. REPORTS EARNINGS
Topics:


Related Articles
MALASKA JOINS TARGETED GENETICS AS ASSOCIATE DIRECTOR OF REGULATORY AFFAIRS
TARGETED GENETICS ELECTS JEREMY CURNOCK COOK TO BOARD OF DIRECTORS
ROBERT FRALEY, PRESIDENT OF CEREGEN, NAMED TO DEKALB GENETICS BOARD OF DIRECTORS
MYRIAD GENETICS, INC. NAMES WOLFGANG HARTWIG, PH.D TO BOARD OF DIRECTORS
BENNO C. SCHMIDT RETIRES AS GENETICS INSTITUTE'S CHAIRMAN OF THE BOARD
TARGETED GENETICS ELECTS THREE NEW BOARD MEMBERS
Genesis Raises Rating on Targeted Genetics to Buy from Hold
Targeted Genetics Reduces Long-Term Cash Obligations Through Conversion of Debt Into Equity.
Lexicon Genetics Elects Clayton S. Rose to Board of Directors.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters